Abstract: Disclosed are a micropore-filled amphoteric membrane for low vanadium ion permeability, a method of manufacturing the same, and a vanadium redox flow battery including the amphoteric membrane. The micropore-filled amphoteric membrane for low vanadium ion permeability minimizes crossover of vanadium ions, which occurs between a catholyte and an anolyte in a redox flow battery, and has low membrane resistance and thus has remarkably improved performance as compared to commercially available ion-exchange membranes such as Nafion, and accordingly, can be effectively used in the manufacture of a redox flow battery. In addition, the micropore-filled amphoteric membrane is continuously manufactured through a roll-to-roll process, and thus the manufacturing process is simple and manufacturing costs can be greatly reduced.

Abstract: The present invention relates to a pharmaceutical composition comprising an interleukin-7 fusion protein to which an immunoglobulin Fc region has been fused for preventing or treating diseases caused by influenza virus A. The fusion protein comprising the immunoglobulin Fc region and IL-7 according to the present invention protects the body from infection due to influenza virus A and thus can treat diseases which can be caused by the virus.

Abstract: An automated chemical formulation apparatus includes: a data reception unit that receives an input chemical material dataset including chemical material information, chemical composition information, chemical formulation information and property information thereof; a predicting model generation unit that trains a first machine learning model using the input chemical material dataset to generate a predicting model for predicting a chemical formulation based on target property information of a target material; and a formulation prediction unit that sets a boundary condition based on the input chemical material dataset, generates a new input dataset including at least one of chemical material information, chemical composition information, and chemical formulation information within the boundary condition, inputs the new input dataset to the predicting model, and sets predetermined one or more pieces of target property information to perform prediction, thereby outputting a first group of chemical formulation da

Abstract: Provided are a monovalent anion selective ion exchange membrane and a method of manufacturing the ion exchange membrane. In regard to the monovalent anion selective ion exchange membrane, a surface portion thereof has a high amount ratio of a cation exchange polymer electrolyte, a central portion thereof has a high amount ratio of an anion exchange polymer electrolyte, and an amount ratio of the anion exchange polymer electrolyte with respect to the cation exchange polymer electrolyte continuously increases in the thickness direction thereof from the surface toward the center. Due to this structure, compared to monovalent anions, polyvalent anions may permeate much less through the exchange membrane. Thus, high selectivity for monovalent anions may be obtained.

Abstract: A data generation apparatus includes a data input unit that inputs an initial dataset, a data preprocessing unit that normalizes the initial dataset and splits the normalized initial dataset into a initial training dataset and a initial test dataset, a learning model generation unit that trains a first machine learning model using the initial training dataset and optimizes a hyperparameter of the first machine learning model using a predetermined number of cross-validations, thereby generating a first learning model, a validation unit that validates the generated first learning model using the initial test dataset, a semi-synthetic data generation unit that selects and generates a new parameter within a boundary space defined by the initial dataset and performs data prediction using the first learning model based on the new parameter to generate a semi-synthetized dataset, and a database that stores the initial dataset and the semi-synthetized dataset.

Abstract: The present invention relates to a pharmaceutical composition comprising an interleukin-7 fusion protein to which an immunoglobulin Fc region has been fused for preventing or treating diseases caused by influenza virus A. The fusion protein comprising the immunoglobulin Fc region and IL-7 according to the present invention protects the body from infection due to influenza virus A and thus can treat diseases which can be caused by the virus.

Abstract: Provided is a matte gray functional building material for windows, comprising: a transparent glass substrate; and a low-emissivity coating formed on one surface of the transparent glass substrate.

Abstract: A functional building material for a window includes a transparent glass substrate; and a low-emissivity coating formed on the transparent glass substrate. The low-emissivity coating includes a vertical sequential stack on the transparent glass substrate of a lowest barrier layer, a first dielectric layer, a lower barrier layer, a second dielectric layer, a first low-emissivity protective layer, a low-emissivity layer, a second low-emissivity protective layer, a third dielectric layer, an upper barrier layer, and a fourth dielectric layer in this order. The lowest barrier layer includes one selected from a group consisting of a first metal, a first complex metal, a first metal oxide, a first complex metal oxide, a first metal oxynitride, a first complex metal oxynitride, and a combination thereof.

Abstract: A pore-filled ion exchange polyelectrolyte composite membrane from which the surface ion exchange polyelectrolyte has been removed and a method of manufacturing the same are provided. The ion exchange polyelectrolyte composite membrane exhibits low film resistance and low in-plane-direction swelling degree, and has a smaller film-thickness than a commercial film, and thus, can be used for various purposes. In addition, since the pore-filled ion exchange polyelectrolyte composite membrane is continuously manufactured through a roll-to-roll process, the manufacturing process is simple, and manufacturing costs can be greatly reduced.

Abstract: Disclosed are a micropore-filled amphoteric membrane for low vanadium ion permeability, a method of manufacturing the same, and a vanadium redox flow battery including the amphoteric membrane. The micropore-filled amphoteric membrane for low vanadium ion permeability minimizes crossover of vanadium ions, which occurs between a catholyte and an anolyte in a redox flow battery, and has low membrane resistance and thus has remarkably improved performance as compared to commercially available ion-exchange membranes such as Nafion, and accordingly, can be effectively used in the manufacture of a redox flow battery. In addition, the micropore-filled amphoteric membrane is continuously manufactured through a roll-to-roll process, and thus the manufacturing process is simple and manufacturing costs can be greatly reduced.

Abstract: Provided are: a low-emissivity coating comprising, in sequence, a first lower dielectric layer, a barrier layer, a second lower dielectric layer, a low-emissivity protective layer, a low-emissivity layer, a low-emissivity protective layer, and an upper dielectric layer; and a functional building material for windows and doors comprising the low-emissivity coating.

Abstract: Provided are: a low-emissivity coating comprising, in sequence, a first lower dielectric layer, a barrier layer, a second lower dielectric layer, a low-emissivity protective layer, a low-emissivity layer, a low-emissivity protective layer, and an upper dielectric layer; and a functional building material for windows and doors comprising the low-emissivity coating.

Abstract: A multichannel fuel cell test station for testing a performance of a fuel cell membrane electrode assembly (MEA) is provided. The multichannel fuel cell test station may include a cell mounting portion configured to receive a plurality of unit cells, a gas supply configured to supply fuel gas to the unit cells and including a pressure generator and a mass flow controller (MFC), a temperature controller configured to maintain a constant ambient temperature of the unit cells, a humidifying portion configured to maintain a constant humidification state around the unit cells, a measurer configured to measure performances and electrochemical impedances of the unit cells, and a controller configured to control the gas supply, the temperature controller, the humidifying portion and the measurer.

Abstract: A functional building material for a window includes a transparent glass substrate; and a low-emissivity coating formed on the transparent glass substrate. The low-emissivity coating includes a vertical sequential stack on the transparent glass substrate of a lowest barrier layer, a first dielectric layer, a lower barrier layer, a second dielectric layer, a first low-emissivity protective layer, a low-emissivity layer, a second low-emissivity protective layer, a third dielectric layer, an upper barrier layer, and a fourth dielectric layer in this order. The lowest barrier layer includes one selected from a group consisting of a first metal, a first complex metal, a first metal oxide, a first complex metal oxide, a first metal oxynitride, a first complex metal oxynitride, and a combination thereof.

Abstract: Provided is a matte gray functional building material for windows, comprising: a transparent glass substrate; and a low-emissivity coating formed on one surface of the transparent glass substrate.

Abstract: The present invention relates to a pharmaceutical composition comprising an interleukin-7 fusion protein to which an immunoglobulin Fc region has been fused for preventing or treating diseases caused by influenza virus A. The fusion protein comprising the immunoglobulin Fc region and IL-7 according to the present invention protects the body from infection due to influenza virus A and thus can treat diseases which can be caused by the virus.

Abstract: The present invention relates to a pharmaceutical composition comprising an immunoglobulin Fc region and an IL-7 fusion protein. Specifically, when a fusion protein comprising the immunoglobulin Fc region and IL-7 is administered to an affected area, a strong immune response is induced in the body and thus allows human papillomavirus-caused diseases to be prevented or treated.